MENU
+Compare
MRK
Stock ticker: NYSE
AS OF
Dec 12 closing price
Price
$100.30
Change
+$1.29 (+1.30%)
Capitalization
248.95B

MRK Merck & Co Forecast, Technical & Fundamental Analysis

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections... Show more

MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MRK with price predictions
Dec 12, 2025

MRK in upward trend: price rose above 50-day moving average on November 05, 2025

MRK moved above its 50-day moving average on November 05, 2025 date and that indicates a change from a downward trend to an upward trend. In of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where MRK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MRK advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 232 cases where MRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MRK moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MRK as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MRK turned negative on December 05, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MRK broke above its upper Bollinger Band on November 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.801) is normal, around the industry mean (8.940). P/E Ratio (13.267) is within average values for comparable stocks, (24.019). Projected Growth (PEG Ratio) (1.056) is also within normal values, averaging (2.056). Dividend Yield (0.032) settles around the average of (0.027) among similar stocks. P/S Ratio (3.934) is also within normal values, averaging (3.677).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MRK is expected to report earnings to fall 20.54% to $2.05 per share on February 03

Merck & Co MRK Stock Earnings Reports
Q4'25
Est.
$2.05
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.09
The last earnings report on October 30 showed earnings per share of $2.58, beating the estimate of $2.35. With 11.81M shares outstanding, the current market capitalization sits at 248.95B.
A.I.Advisor
published Dividends

MRK is expected to pay dividends on January 08, 2026

Merck & Co MRK Stock Dividends
A dividend of $0.85 per share will be paid with a record date of January 08, 2026, and an ex-dividend date of December 15, 2025. The last dividend of $0.81 was paid on October 07. Read more...
A.I. Advisor
published General Information

General Information

a developer of human and animal health products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
126 East Lincoln Avenue
Phone
+1 908 740-4000
Employees
72000
Web
https://www.merck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBIH26.32-0.01
-0.06%
iShares iBonds Oct 2031 Term Tips ETF
FLC17.25-0.06
-0.35%
Flaherty & Crumrine Total Return Fund
CHI10.73-0.04
-0.42%
Calamos Convertible Opportunities and Income Fund
CEPI35.74-0.57
-1.57%
Rex Crypto Equity Premium Income ETF
SPYG105.99-1.76
-1.63%
State Street SPDR Port S&P 500 Gr ETF

MRK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRK has been closely correlated with PFE. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MRK jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.30%
PFE - MRK
68%
Closely correlated
+0.19%
BMY - MRK
58%
Loosely correlated
+2.36%
ABBV - MRK
58%
Loosely correlated
-0.29%
BIIB - MRK
55%
Loosely correlated
+0.93%
AZN - MRK
55%
Loosely correlated
-0.51%
More

Groups containing MRK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRK
1D Price
Change %
MRK100%
+1.30%
MRK
(2 stocks)
99%
Closely correlated
+0.75%